Hong Jun-sik
Seoul National University Hospital|Hematology and Oncology
Seoul Jongno-gu
Last updated
Professor Hong Jun-sik has specialized expertise in blood cell abnormalities and bone marrow disorders, supported by academic activities.
Medical opinions · Patient reviews0
No reviews yet.
If you've been treated by Hong Jun-sik, be the first to leave a review.
Planning to see Hong Jun-sik?
Save this doctor and find them again anytime on My page.
Ask other patients
If reviews don't answer your questions, ask patients and caregivers who have been there.
Patient stories: Hematology and Oncology
MoreHospital information
- Hospitals
- Seoul National University Hospital
- Specialties
- More Hematology and Oncology doctors
- Address
- 101 Daehak-ro, Jongno-gu, Seoul
- University
- 서울대학교 의과대학
- Appointments
- 1588-5700Book by phone (1588-5700)
Education and career
Education
- 2013–2015 Doctorate, Graduate School of Medicine, Gachon University
- 2007–2009 Master of Medicine, Graduate School of Medicine, Gachon University
- 1998–2004 Bachelor of Medicine, Gachon University College of Medicine
Career
- September 2026–Present Professor, Department of Internal Medicine, Seoul National University College of Medicine
- September 2020–August 2022 Long-term visiting scholar, Vanderbilt University, United States
- March 2017–August 2026 Associate Professor, Department of Internal Medicine, Seoul National University College of Medicine
- March 2011–January 2017 Assistant Professor, Department of Internal Medicine, Gachon University College of Medicine
- March 2009–February 2010 Clinical Fellow, Division of Hematology and Oncology, Seoul National University Hospital
- Title: Phase II study of combined belotecan and cisplatin as first-line chemotherapy in patients with extensive disease of small cell lung cancer
- Journal: Cancer Chemother Pharmacol
- Publication date: January 2012
- Title: Evaluation of prognostic values of clinical and histopathologic characteristics in diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy
- Journal: Leuk Lymphoma
- Publication date: October 2011
- Title: Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma
- Journal: Ann Hematol
- Publication date: May 2012
- Title: CD99 expression and newly diagnosed diffuse large B-cell lymphoma treated with rituximab-CHOP immunochemotherapy
- Journal: Ann Hematol
- Publication date: December 2012
- Title: Limitation in the assessment of baseline lymphomatous bone marrow involvement by FDG-PET/CT scan
- Journal: Ann Hematol
- Publication date: April 2013
Academic societies
- 2010–Present American Society of Hematology / International Member
- 2009–Present Korean Society of Clinical Oncology / Regular Member
- 2009–Present Korean Cancer Association / Regular Member
- 2009–Present Korean Society for Blood and Marrow Transplantation / Regular Member
- 2009–Present Korean Society of Hematology / Regular Member
FAQ
- What conditions does Hong Jun-sik treat?
- Hong Jun-sik (Hematology and Oncology, Seoul National University Hospital) treats conditions such as Myelodysplastic syndrome, Myeloproliferative neoplasms, Hematopoietic stem cell transplantation.
- Where does Hong Jun-sik see patients?
- In Hematology and Oncology at Seoul National University Hospital. The hospital address is 101 Daehak-ro, Jongno-gu, Seoul.
- What is Hong Jun-sik's specialty?
- Specialty: Hematology and Oncology.
Is any information wrong?
Let us know about changes to hospital, specialty, career and so on, and we'll update it after checking.